Study of Lenalidomide/Ixazomib/Dexamethasone/Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed MM
Clinical trial NCT04009109 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04009109
- Sponsor
- Alliance Foundation Trials, LLC.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-21
- Primary completion
- 2026-12-01
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.